Marco Valgimigli

Marco Valgimigli

Deputy Chief of Cardiology

Istituto Cardiocentro Ticino, Lugano, CH

  • Radcliffe

Biography

Prof Marco Valgimigli is an Interventional Cardiologist and Deputy Chief of Cardiology at the Cardiocentro Ticino Institute in Lugano, Switzerland.

He obtained his medical degree from the University of Bologna, and completed his training in internal medicine at the same university. He received a degree in cardiological sciences at the University of Ferrara and a PhD in interventional cardiology at Erasmus Medical Center in Rotterdam.

Prof Valgimigli’s areas of research are wide ranging and include high-risk percutaneous interventions (PCI); invasive treatment of myocardial ischaemia (MI); reparative medicine with adult stem cells during MI and heart failure; antithrombotic therapy during and after PCI; and prognostic stratification during acute coronary syndromes and MI.

Read more

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

BIOFLOW-DAPT: Orsiro Mission Proven to be Safe and Effective

Marco Valgimigli,

Watch time: 5m 35s

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Marco Valgimigli, Eliano Navarese, Pascal Vranckx, et al

Watch time: 1h 48m 18s (11 videos)

Marco Valgimigli, Vijay Kunadian, Pascal Vranckx, et al

Watch time: 1h 37m 46s

Roxana Mehran, Pascal Vranckx, Marco Valgimigli, et al

Watch time: 1h 27m 41s (4 videos)
ESC 22: P2Y12i Vs Aspirin Monotherapy in CAD Pts

Marco Valgimigli,

Watch time: 4m 59s
ESC 22: MASTER DAPT Results at 15M with Prof Valgimigli

Marco Valgimigli,

Watch time: 4m 13s
EuroPCR 22: MASTER-DAPT Sub-Analysis Shows Consistent Results in Complex PCI Patients

Marco Valgimigli,

Watch time: 5m 56s
MASTER-DAPT Sub-Analysis Shows Consistent Results in Complex PCI Patients

Marco Valgimigli,

Watch time: 5m 56s

Nicolas M Van Mieghem, Simone Biscaglia, Ajay J Kirtane, et al

Watch time: 2h 20m 24s (21 videos)

Prof Marek Grygier, Jens-Erik Nielsen-Kudsk, Adel Aminian, et al

USC 2021 Discussion: Optimal Antiplatelet Regimen in High Bleeding Risk

Mirvat Alasnag, Khaled Al-Shaibi, Roisin Colleran, et al

Watch time: 21m 10s
ESC 2018: MATRIX Trial

Marco Valgimigli,

Watch time: 5m 12s
EuroPCR 2016: Master DAPT study announcement

Marco Valgimigli, Pieter C Smits,

Watch time: 8m 43s

Articles by Marco Valgimigli, Deputy Chief of Cardiology

The Significance of Drug–Drug and Drug–Food Interactions of Oral Anticoagulation

Pascal Vranckx, Marco Valgimigli, Hein Heidbuchel, et al

Citation: Arrhythmia & Electrophysiology Review 2018;7(1):55–61.

DOI:

https://doi.org/10.15420/aer.2017.50.1
Dual Antiplatelet Therapy After Drug-eluting Stent Implantation

Giulia Magnani, Marco Valgimigli,

Citation: Interventional Cardiology Review 2016;11(1):51–3

DOI:

https://doi.org/10.15420/icr.2015:17:2
Meeting the Unmet – The Cre8 Polymer-free Drug-eluting Stents Technology

Didier Carrie, Marco Valgimigli, Gennaro Sardella, et al

Citation: Interventional Cardiology Review 2014;9(3):184–9

DOI:

https://doi.org/10.15420/icr.2014.9.3.184